Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Sparfloxacin

A fluoroquinolone antibiotic patented in 1985 and approved in 1993, used mainly for respiratory tract infections such as pneumonia, sinusitis and flare-ups of chronic bronchitis. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.

Did you know?It belongs to the family born from nalidixic acid, the first quinolone, discovered in the 1960s by George Lesher as a by-product of the manufacture of the antimalarial chloroquine.

SparfloxacinGo to the active ingredient →
SparfloxacinActive ingredientSparfloxacinCat. No. P-S072-001CAS 110871-86-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.